Hereditary Cancer: Example of a Public Health Approach to Ensure Population Health Benefits of Genetic Medicine

This article introduces the identification, prevention, and treatment of hereditary cancer as an important public health concern. Hereditary cancer research and educational outreach activities are used to illustrate how public health functions can help to achieve health benefits of genetic and genom...

Full description

Bibliographic Details
Main Authors: Deborah Cragun, Courtney Lewis, Lucia Camperlengo, Tuya Pal
Format: Article
Language:English
Published: MDPI AG 2016-01-01
Series:Healthcare
Subjects:
Online Access:http://www.mdpi.com/2227-9032/4/1/6
id doaj-69c40ff8755f4b29b34c48851c14fef0
record_format Article
spelling doaj-69c40ff8755f4b29b34c48851c14fef02020-11-25T00:46:41ZengMDPI AGHealthcare2227-90322016-01-0141610.3390/healthcare4010006healthcare4010006Hereditary Cancer: Example of a Public Health Approach to Ensure Population Health Benefits of Genetic MedicineDeborah Cragun0Courtney Lewis1Lucia Camperlengo2Tuya Pal3College of Public Health, Department of Global Health, University of South Florida, Tampa, FL 33620, USAMoffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USAMoffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USAMoffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USAThis article introduces the identification, prevention, and treatment of hereditary cancer as an important public health concern. Hereditary cancer research and educational outreach activities are used to illustrate how public health functions can help to achieve health benefits of genetic and genomic medicine. First, we evaluate genetic service delivery through triangulating patient and provider survey results which reveal variability among providers in hereditary cancer knowledge and genetic service provision. Second, we describe efforts we have made to assure competency among healthcare providers and to inform, educate and empower patients with regard to the rapidly evolving field of genomics and hereditary cancer. Lastly, key policy-issues raised by our experiences are discussed in the context of how they may help us to more effectively translate future genomic technologies into practice in order to attain population health benefits from genetic and genomic medicine.http://www.mdpi.com/2227-9032/4/1/6genetic testinghereditary breast and ovarian cancer syndromegenomicspublic health
collection DOAJ
language English
format Article
sources DOAJ
author Deborah Cragun
Courtney Lewis
Lucia Camperlengo
Tuya Pal
spellingShingle Deborah Cragun
Courtney Lewis
Lucia Camperlengo
Tuya Pal
Hereditary Cancer: Example of a Public Health Approach to Ensure Population Health Benefits of Genetic Medicine
Healthcare
genetic testing
hereditary breast and ovarian cancer syndrome
genomics
public health
author_facet Deborah Cragun
Courtney Lewis
Lucia Camperlengo
Tuya Pal
author_sort Deborah Cragun
title Hereditary Cancer: Example of a Public Health Approach to Ensure Population Health Benefits of Genetic Medicine
title_short Hereditary Cancer: Example of a Public Health Approach to Ensure Population Health Benefits of Genetic Medicine
title_full Hereditary Cancer: Example of a Public Health Approach to Ensure Population Health Benefits of Genetic Medicine
title_fullStr Hereditary Cancer: Example of a Public Health Approach to Ensure Population Health Benefits of Genetic Medicine
title_full_unstemmed Hereditary Cancer: Example of a Public Health Approach to Ensure Population Health Benefits of Genetic Medicine
title_sort hereditary cancer: example of a public health approach to ensure population health benefits of genetic medicine
publisher MDPI AG
series Healthcare
issn 2227-9032
publishDate 2016-01-01
description This article introduces the identification, prevention, and treatment of hereditary cancer as an important public health concern. Hereditary cancer research and educational outreach activities are used to illustrate how public health functions can help to achieve health benefits of genetic and genomic medicine. First, we evaluate genetic service delivery through triangulating patient and provider survey results which reveal variability among providers in hereditary cancer knowledge and genetic service provision. Second, we describe efforts we have made to assure competency among healthcare providers and to inform, educate and empower patients with regard to the rapidly evolving field of genomics and hereditary cancer. Lastly, key policy-issues raised by our experiences are discussed in the context of how they may help us to more effectively translate future genomic technologies into practice in order to attain population health benefits from genetic and genomic medicine.
topic genetic testing
hereditary breast and ovarian cancer syndrome
genomics
public health
url http://www.mdpi.com/2227-9032/4/1/6
work_keys_str_mv AT deborahcragun hereditarycancerexampleofapublichealthapproachtoensurepopulationhealthbenefitsofgeneticmedicine
AT courtneylewis hereditarycancerexampleofapublichealthapproachtoensurepopulationhealthbenefitsofgeneticmedicine
AT luciacamperlengo hereditarycancerexampleofapublichealthapproachtoensurepopulationhealthbenefitsofgeneticmedicine
AT tuyapal hereditarycancerexampleofapublichealthapproachtoensurepopulationhealthbenefitsofgeneticmedicine
_version_ 1725263784019230720